Marginal: It is primarily being used to treat recurrent malignant gliomas . The latest results with its use as a frontline treatment for malignant glioma show no real benefit over the current conventional regimen using radiation therapy and chemotherapy with temodar (temozolomide).
Answered 12/20/2014
5.1k views
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
3 doctors weighed in across 2 answers
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question